Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Change in Account Payables (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Change in Account Payables for 9 consecutive years, with -$10000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables fell 104.07% to -$10000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$145000.0, a 310.14% decrease, with the full-year FY2024 number at -$1.4 million, down 191.98% from a year prior.
  • Change in Account Payables was -$10000.0 for Q3 2025 at SANUWAVE Health, up from -$149000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q4 2023 to a low of -$643000.0 in Q1 2024.
  • A 3-year average of $35272.7 and a median of -$146000.0 in 2023 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 196.85% in 2024; the steepest drop was 321.92% in 2024.
  • SANUWAVE Health's Change in Account Payables stood at $1.1 million in 2023, then crashed by 137.8% to -$409000.0 in 2024, then surged by 97.56% to -$10000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Change in Account Payables are -$10000.0 (Q3 2025), -$149000.0 (Q2 2025), and $423000.0 (Q1 2025).